EichorEICHOR
Study identifier: NCT04224493 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

Condition: Relapsed/Refractory Follicular Lymphoma · Follicular Lymphoma · Refractory Follicular Lymphoma  ·  Sponsor: Epizyme, Inc.

PhasePhase 3
Planned participants599
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (204)

Southern Cancer CenterMobile, Alabama, United States
Arizona Oncology Associates - Tuscon-Rusadill RoadTucson, Arizona, United States
TOI - Clinical ResearchCerritos, California, United States
UCSF FresnoClovis, California, United States
UC San Diego Health SciencesLa Jolla, California, United States
UCLA Clinical Research Unit Hematology/OncologySanta Monica, California, United States
Rocky Mountain Cancer Centers (RMCC) - BoulderBoulder, Colorado, United States
St. Mary's Hospital and Regional Medical Center - St. Mary'sGrand Junction, Colorado, United States
Cancer Specialists of North FloridaFleming Island, Florida, United States
Florida Cancer Specialists & Research Institute (FCS) - Fort Myers Cancer CenterFort Myers, Florida, United States
Mayo ClinicJacksonville, Florida, United States
Florida Cancer Affiliates/Ocala Oncology - ClinicOcala, Florida, United States

+ 192 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →